Clinical significance of changes of serum GDF-15, NT-proBNP and cTnI levels and its relationship with short-term prognosis in patients with cardiopulmonary resuscitation
Author:
Affiliation:

1.Department of Emergency, ;2.Department of ICU, Central Hospital of Chengde City, Chengde, Hebei 067000, China)

Clc Number:

R459.7

  • Article
  • | |
  • Metrics
  • |
  • Reference [14]
  • | | | |
  • Comments
    Abstract:

    Aim To investigate the clinical significance of serum growth differentiation factor 15 (GDF-15), N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac troponin I (cTnI) changes at different time and its relationship with short-term prognosis in patients with cardiac arrest cardiopulmonary resuscitation. Methods The serum levels of GDF-15 were detected in 102 CPR patients at instant time, 12 h, 24-48 h after CPR. According to the rise time of serum GDF-15, the patients were divided into 3 groups:(1)A group:at instant time, 12 h, 24-48 h after CPR, GDF-15 levels had been less than 1200 ng/L; (2)B group:at 12 h and 24-48 h after CPR, GDF-15 levels were increased, and more than 1200 ng/L; (3)C group:at instant time, 12 h after CPR, GDF-15 levels were increased, but GDF-15 level at 24-48 h was lower than that at 12 h. At each time point, the serum levels of NT-proBNP and cTnI, left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) were detected at the same time in 3 groups. The death situation of 3 groups was followed up for 6 months after CPR. Results GDF-15 had an interaction with NT-proBNP and cTnI (P=0.001). LVEDD and LVEF were changed with the changes of GDF-15, NT-proBNP and cTnI levels. The mortality rates of patients in GDF-15, NT-proBNP and cTnI high level groups were higher than those in GDF-15, NT-proBNP and cTnI low level groups (P<0.05). Survival analysis results showed that the 6 month survival rate of A group was higher than that of B group (χ2=12.738, P=0.001), the 6 month survival rate of B group was lower than that of C group (χ2=7.253, P=0.009), and there was no significant difference in 6 month survival rate between A group and C group (χ2=2.240, P=0.097). Conclusion The serum levels of GDF-15, NT-proBNP and cTnI are good indicators for predicting the short-term prognosis of CPR patients, and the significance of combined detection is even higher.

    Reference
    [1] Kempf T, Eden M, Strelau J, et al.The transforming growth factor-beta superfamily member growth defferentiation factor-15 protecters the heart from ischemia/reperfusion injury.Cire Res, 6,8(3):351-360.
    [2] Friedl W, Mair J, Thomas S, et al.Relatlonship between natriuretic peptide and hemodynamics in patients heart failure at rest and after ergometrie exercise.Clin Chim Acta, 9,1(12):121-126.
    [3] Gil M, Zarebiske M, Adamus J, et al.Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina.Int J Cardiol, 7,3(6):43-46.
    [4] Bron DA, Breit SN, Buring J, et al.Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women:a nested case control study.Lancet, 2,9(9):2 159-163.
    [5] Xu J, Kimball TR, Lorenz JN, et al.MIC-1 function as a protective antihypertrophic factor released from the myocadium in association with SMAD protein activation.Cire Res, 6,8(3):342-350.
    [6] Bootcov MR, Bauskin AR, Valenzuela SM, et al.MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily.Proc Natl Acad Sci USA, 7,4(21):11 514-519.
    [7] Tan M, Wang Y, Guan K, et al.PTGF-beta, a type beta transforming frowth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.Proc Natl Acad Sci USA, 9,7(5):109-114.
    [8] Kempf T, Wollert KC.Growth differrentiaton factor-15:a new biomarkerin cardiovascular disease.Herz, 9,4(6):594-599.
    [9] Kempf T, Widera C, Bavendiek U.Growth differentiationg factor-15 promotes anti-inflammatory effects and enhances survival after experimental myocardial in farcion.Circulation, 7,6(2):160-165.
    [10] Maisel A.Biomarkers in heart failure:Does prognostic utility translate to clinical futility?.J Am Coll Cardiol, 7,0(11):1 054-060.
    [11] Lind L, Wallentin L, Kempf T, et al.Growth differentiation factor-15 is an independent marker of cardiovascular function and disease in the elderly:results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.Eur Heart J, 9,0(8):2 346-353.
    [12] Tsuruda T, Boerrigter G, Huntley BK, et al.Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases.Cir Res, 2,1(11):1 127-134.
    [13] 曹志民, 于海侠, 檀立端, 等.心脏骤停患者心肺复苏成功后利钠肽水平变化与预后关系的研究.中国循环杂志, 5,0(9):859-862.
    [14] 郭云涛, 王兴祥.AMI患者Mb、cTnI、hs-CPR和NT-proBNP水平变化与临床意义.心脑血管病防治, 9,9(1):43-45.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

YU Hai-Xia, ZHOU Jing-Xia, REN Chang-An, WU Hui-Zhi, LI Zhong, LIU Chun-Tao. Clinical significance of changes of serum GDF-15, NT-proBNP and cTnI levels and its relationship with short-term prognosis in patients with cardiopulmonary resuscitation[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(3):269-273.

Copy
Share
Article Metrics
  • Abstract:1116
  • PDF: 932
  • HTML: 0
  • Cited by: 0
History
  • Received:July 24,2016
  • Revised:September 03,2016
  • Online: March 28,2017
Article QR Code